Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics

BMC Immunology

Volumn 15, Issue 1, 2014, Pages

  Winkler, Carla ^a,b   Witte, Lena ^a,b   Moraw, Natali ^b   Faulenbach, Conny ^b   Müller, Meike ^b   Holz, Olaf ^b,c   Schaumann, Frank ^b   Hohlfeld, Jens M ^a,b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^c Member of the German Center for Lung Research   (Germany)

Author keywords

Asthma; Endobronchial allergen provocation; M2 macrophages; Segmental allergen challenge

Indexed keywords

ALLERGEN; ARGINASE; CD86 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 4; PROTEIN; PROTEIN FIZZ1; PROTEIN YM1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC AIRWAY INFLAMMATION; ANIMAL MODEL; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHILIA; EX VIVO STUDY; FEMALE; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; PROVOCATION TEST; SYSTEMATIC REVIEW;

ADULT; ALLERGENS; ANIMALS; ASTHMA; BIOLOGICAL MARKERS; BRONCHIAL PROVOCATION TESTS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; LUNG; LYMPHOCYTE ACTIVATION; MACROPHAGES; MACROPHAGES, ALVEOLAR; MALE; MICE; MIDDLE AGED;

EID: 84897538947     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-15-12     Document Type: Article

References (54)

1. Kazani S, Israel E. Update in asthma 2011. Am J Respir Crit Care Med 2012, 186:35-40. 10.1164/rccm.201204-0634UP, 3400997, 22753688.
2. Kool M, Hammad H, Lambrecht BN. Cellular networks controlling Th2 polarization in allergy and immunity. F1000 Biol Rep 2012, 4:6. 3292286, 22403589.
3. Willart M, Hammad H. Lung dendritic cell-epithelial cell crosstalk in Th2 responses to allergens. Curr Opin Immunol 2011, 23:772-777. 10.1016/j.coi.2011.09.008, 22074731.
4. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am J Respir Cell Mol Biol 2004, 31:3-7. 10.1165/rcmb.f279, 15208096.
5. Yang M, Kumar RK, Hansbro PM, Foster PS. Emerging roles of pulmonary macrophages in driving the development of severe asthma. J Leukoc Biol 2012, 91:557-569. 10.1189/jlb.0711357, 22293472.
6. Boorsma CE, Draijer C, Melgert BN. Macrophage Heterogenity in Respiratory Diseases. Mediators Inflamm 2013, 769214. 19 pages.
7. Noel W, Raes G, Hassanzadeh GG, De BP, Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol 2004, 20:126-133. 10.1016/j.pt.2004.01.004, 15036034.
8. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896. 10.1038/ni.1937, 20856220.
9. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013, 229:176-185. 10.1002/path.4133, 23096265.
10. Raes G, De BP, Noel W, Beschin A, Brombacher F, Hassanzadeh GG. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 2002, 71:597-602.
11. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992, 176:287-292. 10.1084/jem.176.1.287, 2119288, 1613462.
12. Melgert BN, Ten Hacken NH, Rutgers B, Timens W, Postma DS, Hylkema MN. More alternative activation of macrophages in lungs of asthmatic patients. J Allergy Clin Immunol 2011, 127:831-833. 10.1016/j.jaci.2010.10.045, 21167569.
13. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686. 10.1016/j.it.2004.09.015, 15530839.
14. Martinez FO, Helming L, Milde R, Varin A, Melgert BN, Draijer C, Thomas B, Fabbri M, Crawshaw A, Ho LP, Ten Hacken NH, Cobos Jiménez V, Kootrat NA, Hamann J, Greaves DR, Locatti M, Mantovani A, Gordon S. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 2013, 121:e57-e69. 10.1182/blood-2012-06-436212, 23293084.
15. Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C, Djukanovic R. Phenotypic characterization of lung macrophages in asthmatic patients: Overexpression of CCL17. J Allergy Clin Immunol 2012, 130:1404-1412. 10.1016/j.jaci.2012.07.023, 3805016, 22981793.
16. Schaumann F, Muller M, Braun A, Luettig B, Peden DB, Hohlfeld JM, Krug N. Endotoxin augments myeloid dendritic cell influx into the airways in patients with allergic asthma. Am J Respir Crit Care Med 2008, 177:1307-1313. 10.1164/rccm.200706-870OC, 2427055, 18388357.
17. Vijayanand P, Durkin K, Hartmann G, Morjaria J, Seumois G, Staples KJ, Hall D, Bessant C, Bartholomew M, Howarth PH, Friedman PS, Djukanović R. Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients. J Immunol 2010, 184:4568-4574. 10.4049/jimmunol.0901342, 20237293.
18. Pilette C, Francis JN, Till SJ, Durham SR. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J 2004, 23:876-884. 10.1183/09031936.04.00102504, 15219001.
19. Krysko O, Holtappels G, Zhang N, Kubica M, Deswarte K, Derycke L, Claeys S, Hammad H, Brusselle GG, Vandenabeele P, Krysko DV, Bachert C. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy 2011, 66:396-403. 10.1111/j.1398-9995.2010.02498.x, 20973804.
20. Liddiard K, Welch JS, Lozach J, Heinz S, Glass CK, Greaves DR. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol Biol 2006, 7:45. 10.1186/1471-2199-7-45, 1698493, 17134490.
21. Perros F, Hoogsteden HC, Coyle AJ, Lambrecht BN, Hammad H. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Allergy 2009, 64:995-1002. 10.1111/j.1398-9995.2009.02095.x, 19630858.
22. Heijink IH, Marcel KP, van Oosterhout AJ, Postma DS, Kauffman HF, Vellenga E. Der p, IL-4, and TGF-beta cooperatively induce EGFR-dependent TARC expression in airway epithelium. Am J Respir Cell Mol Biol 2007, 36:351-359. 10.1165/rcmb.2006-0160OC, 17023689.
23. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001, 24:382-389. 10.1165/ajrcmb.24.4.4360, 11306430.
24. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, Robinson D, Zhang G, Zhao J, Lee TH, Corrigan C. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005, 174:8183-8190.
25. Hirata H, Arima M, Cheng G, Honda K, Fukushima F, Yoshida N, Eda F, Fukuda T. Production of TARC and MDC by naive T cells in asthmatic patients. J Clin Immunol 2003, 23:34-45. 10.1023/A:1021948214742, 12645858.
26. Kalayci O, Sonna LA, Woodruff PG, Camargo CA, Luster AD, Lilly CM. Monocyte chemotactic protein-4 (MCP-4; CCL-13): a biomarker of asthma. J Asthma 2004, 41:27-33. 10.1081/JAS-120024590, 15046375.
27. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002, 38:881-885. 10.1016/S0161-5890(02)00013-5, 12009564.
28. Lamkhioued B, Garcia-Zepeda EA, Abi-Younes S, Nakamura H, Jedrzkiewicz S, Wagner L, Renzi PM, Allakhverdi Z, Lilly C, Hamid Q, Luster AD. Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med 2000, 162:723-732. 10.1164/ajrccm.162.2.9901080, 10934112.
29. Sano Y, Usami K, Izawa R, Denda-Nagai K, Higashi N, Kimura T, Suzuki N, Irimura T. Properties of blocking and non-blocking monoclonal antibodies specific for human macrophage galactose-type C-type lectin (MGL/ClecSF10A/CD301). J Biochem 2007, 141:127-136.
30. Wolden B, Smesta PB, Wold JK, Grimmer O. Characterization of the carbohydrate moiety in a purified allergen preparation from the mite Dermatophagoides farinae and its importance for allergenic activity as tested by rast-inhibition method. Int Arch Allergy Appl Immunol 1982, 68:144-151. 10.1159/000233084, 6281198.
31. Viksman MY, Bochner BS, Peebles RS, Schleimer RP, Liu MC. Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge. Clin Immunol 2002, 104:77-85. 10.1006/clim.2002.5233, 12139951.
32. Fitzpatrick AM, Holguin F, Teague WG, Brown LA. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol 2008, 121:1372-1378. 10.1016/j.jaci.2008.03.008, 2442216, 18417198.
33. Huynh ML, Malcolm KC, Kotaru C, Tilstra JA, Westcott JY, Fadok VA, Wenzel SE. Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am J Respir Crit Care Med 2005, 172:972-979. 10.1164/rccm.200501-035OC, 16040786.
34. Alexis NE, Soukup J, Nierkens S, Becker S. Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. Am J Physiol Lung Cell Mol Physiol 2001, 280:L369-L375.
35. Varin A, Mukhopadhyay S, Herbein G, Gordon S. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 2010, 115:353-362. 10.1182/blood-2009-08-236711, 2808158, 19880493.
36. Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, Reed J, Coyle AJ, Kiener P, Cullen M, Grandsaigne M, Dombret MC, Aubier M, Pretolani M, Elias JA. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007, 357:2016-2027. 10.1056/NEJMoa073600, 18003958.
37. Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF, Nicolae DL, Elias JA, Chupp GL. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008, 358:1682-1691. 10.1056/NEJMoa0708801, 2629486, 18403759.
38. Tang H, Fang Z, Sun Y, Li B, Shi Z, Chen J, Zhang T, Xiu Q. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 2010, 35:757-760. 10.1183/09031936.00034409, 20356987.
39. Lee CG, Dela Cruz CS, Herzog E, Rosenberg SM, Ahangari F, Elias JA. YKL-40, a chitinase-like protein at the intersection of inflammation and remodeling. Am J Respir Crit Care Med 2012, 185:692-694. 10.1164/rccm.201202-0203ED, 22467800.
40. Gavala ML, Kelly EA, Esnault S, Kukreja S, Evans MD, Bertics PJ, Chupp GL, Jarjour NN. Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma. Clin Exp Allergy 2013, 43:187-197. 10.1111/cea.12032, 3623278, 23331560.
41. de Nadai P, Charbonnier AS, Chenivesse C, Senechal S, Fournier C, Gilet J, Vorng H, Chang Y, Gosset P, Wallaert B, Tonnel AB, Lassalle P, Tsicopoulos A. Involvement of CCL18 in allergic asthma. J Immunol 2006, 176:6286-6293.
42. Luzina IG, Highsmith K, Pochetuhen K, Nacu N, Rao JN, Atamas SP. PKCalpha mediates CCL18-stimulated collagen production in pulmonary fibroblasts. Am J Respir Cell Mol Biol 2006, 35:298-305. 10.1165/rcmb.2006-0033OC, 2643282, 16601239.
43. Lensmar C, Katchar K, Eklund A, Grunewald J, Wahlstrom J. Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma. Respir Med 2006, 100:918-925. 10.1016/j.rmed.2005.08.014, 16202577.
44. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G, Thepen T. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993, 177:397-407. 10.1084/jem.177.2.397, 2190916, 8426110.
45. Nieuwenhuizen NE, Kirstein F, Jayakumar J, Emedi B, Hurdayal R, Horsnell WG, Lopata AL, Brombacher F. Allergic airway disease is unaffected by the absence of IL-4Ralpha-dependent alternatively activated macrophages. J Allergy Clin Immunol 2012, 130:743-750. 10.1016/j.jaci.2012.03.011, 22552110.
46. Ford AQ, Dasgupta P, Mikhailenko I, Smith EM, Noben-Trauth N, Keegan AD. Adoptive transfer of IL-4Ralpha + macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunol 2012, 13:6. 10.1186/1471-2172-13-6, 3283450, 22292924.
47. Herbert C, Scott MM, Scruton KH, Keogh RP, Yuan KC, Hsu K, Siegle JS, Tedla N, Foster PS, Kumar RK. Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma. Am J Pathol 2010, 177:1657-1664. 10.2353/ajpath.2010.100019, 2947263, 20724599.
48. Nagarkar DR, Bowman ER, Schneider D, Wang Q, Shim J, Zhao Y, Linn MJ, McHenry CL, Gosangi B, Bentley JK, Tsai WC, Sajjan US, Lukacs NW, Hershenson MB. Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. J Immunol 2010, 185:2525-2535. 10.4049/jimmunol.1000286, 3208235, 20644177.
49. Nassenstein C, Dawbarn D, Pollock K, Allen SJ, Erpenbeck VJ, Spies E, Krug N, Braun A. Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J Allergy Clin Immunol 2006, 118:597-605. 10.1016/j.jaci.2006.04.052, 16950277.
50. Atochina-Vasserman EN, Winkler C, Abramova H, Schaumann F, Krug N, Gow AJ, Beers MF, Hohlfeld JM. Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans. Am J Respir Crit Care Med 2011, 183:856-864. 10.1164/rccm.201004-0654OC, 3086753, 21131470.
51. Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A, Krug N. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 2003, 111:1319-1327. 10.1067/mai.2003.1485, 12789235.
52. Knothe S, Mutschler V, Rochlitzer S, Winkler C, Ebensen T, Guzman CA, Hohlfeld J, Braun A, Muller M. The NKT cell ligand alphagalactosylceramide suppresses allergic airway inflammation by induction of a Th1 response. Vaccine 2011, 29:4249-4255. 10.1016/j.vaccine.2011.03.068, 21463684.
53. Winkler AR, Nocka KH, Sulahian TH, Kobzik L, Williams CM. In vitro modeling of human alveolar macrophage smoke exposure: enhanced inflammation and impaired function. Exp Lung Res 2008, 34:599-629. 10.1080/01902140802366261, 19005923.
54. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.